Murphree-Terry M, Keith J, Oden A, Birket S
Am J Physiol Lung Cell Mol Physiol. 2024; 327(5):L672-L683.
PMID: 39316674
PMC: 11563644.
DOI: 10.1152/ajplung.00381.2023.
Lebrun-Corbin M, Cheung B, Hullahalli K, Dailey K, Bailey K, Waldor M
bioRxiv. 2024; .
PMID: 39229171
PMC: 11370369.
DOI: 10.1101/2024.08.19.608679.
Pangeni R, Poudel S, Momin M, Farkas D, Dalton C, Hall F
Int J Pharm. 2024; 662:124504.
PMID: 39053676
PMC: 11344668.
DOI: 10.1016/j.ijpharm.2024.124504.
Yu H, Xu Y, Imani S, Zhao Z, Ullah S, Wang Q
ACS Infect Dis. 2024; 10(7):2336-2355.
PMID: 38866389
PMC: 11249778.
DOI: 10.1021/acsinfecdis.4c00007.
Dartois V, Bonfield T, Boyce J, Daley C, Dick T, Gonzalez-Juarrero M
Tuberculosis (Edinb). 2024; 147:102503.
PMID: 38729070
PMC: 11168888.
DOI: 10.1016/j.tube.2024.102503.
Biologically Relevant Murine Models of Chronic Respiratory Infection.
Rodgers A, Lindsay J, Monahan A, Dubois A, Faniyi A, Plant B
Pathogens. 2023; 12(8).
PMID: 37624013
PMC: 10458525.
DOI: 10.3390/pathogens12081053.
Persistence Level Reflects Antibiotic Survival of Natural Pseudomonas aeruginosa Isolates in a Murine Lung Infection Model.
Verstraete L, Aizawa J, Govaerts M, De Vooght L, Lavigne R, Michiels J
Microbiol Spectr. 2023; 11(3):e0497022.
PMID: 37140371
PMC: 10269860.
DOI: 10.1128/spectrum.04970-22.
To bead or not to bead: A review of lung infection models for cystic fibrosis.
Reyne N, McCarron A, Cmielewski P, Parsons D, Donnelley M
Front Physiol. 2023; 14:1104856.
PMID: 36824474
PMC: 9942929.
DOI: 10.3389/fphys.2023.1104856.
Selected strategies to fight pathogenic bacteria.
Plotniece A, Sobolev A, Supuran C, Carta F, Bjorkling F, Franzyk H
J Enzyme Inhib Med Chem. 2023; 38(1):2155816.
PMID: 36629427
PMC: 9848314.
DOI: 10.1080/14756366.2022.2155816.
: Infections, Animal Modeling, and Therapeutics.
Wood S, Kuzel T, Shafikhani S
Cells. 2023; 12(1).
PMID: 36611992
PMC: 9818774.
DOI: 10.3390/cells12010199.
and Antibacterial Effects of Frankincense Oil and Its Interaction with Some Antibiotics against Multidrug-Resistant Pathogens.
Almutairi M, Alrouji M, Almuhanna Y, Asad M, Joseph B
Antibiotics (Basel). 2022; 11(11).
PMID: 36358246
PMC: 9686721.
DOI: 10.3390/antibiotics11111591.
An model for the cultivation of polymicrobial biofilms under continuous-flow conditions.
OBrien T, Hassan M, Harrison F, Welch M
F1000Res. 2021; 10:801.
PMID: 34557293
PMC: 8442117.
DOI: 10.12688/f1000research.55140.1.
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections.
Plaunt A, Rose S, Kang J, Chen K, LaSala D, Heckler R
Antimicrob Agents Chemother. 2021; 65(7):e0031621.
PMID: 33941518
PMC: 8373216.
DOI: 10.1128/AAC.00316-21.
Review of Potential Weaponry, Relevant to the Interplay, for the Mycology Community.
Chatterjee P, Sass G, Swietnicki W, Stevens D
J Fungi (Basel). 2020; 6(2).
PMID: 32517271
PMC: 7345761.
DOI: 10.3390/jof6020081.
Lung regeneration: a tale of mice and men.
Basil M, Morrisey E
Semin Cell Dev Biol. 2019; 100:88-100.
PMID: 31761445
PMC: 7909713.
DOI: 10.1016/j.semcdb.2019.11.006.
Controlling chronic Pseudomonas aeruginosa infections by strategically interfering with the sensory function of SagS.
Dingemans J, Al-Feghali R, Lau G, Sauer K
Mol Microbiol. 2019; 111(5):1211-1228.
PMID: 30710463
PMC: 6488366.
DOI: 10.1111/mmi.14215.
Options and Limitations in Clinical Investigation of Bacterial Biofilms.
Magana M, Sereti C, Ioannidis A, Mitchell C, Ball A, Magiorkinis E
Clin Microbiol Rev. 2018; 31(3).
PMID: 29618576
PMC: 6056845.
DOI: 10.1128/CMR.00084-16.
Airway disease phenotypes in animal models of cystic fibrosis.
McCarron A, Donnelley M, Parsons D
Respir Res. 2018; 19(1):54.
PMID: 29609604
PMC: 5879563.
DOI: 10.1186/s12931-018-0750-y.
A multi-host approach to identify a transposon mutant of Pseudomonas aeruginosa LESB58 lacking full virulence.
Gagne-Thivierge C, Kukavica-Ibrulj I, Filion G, Dekimpe V, Tan S, Vincent A
BMC Res Notes. 2018; 11(1):198.
PMID: 29580289
PMC: 5870910.
DOI: 10.1186/s13104-018-3308-7.
Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
Gomi R, Sharma A, Wu W, Sung B, Worgall S
Vaccine. 2017; 35(51):7174-7180.
PMID: 29126807
PMC: 5752147.
DOI: 10.1016/j.vaccine.2017.10.078.